Sharon Horton, MD
MOHS-Micrographic Surgery · Batavia, ILNPI 1538153960
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Galderma Laboratories, L.p. at 25.1% of the total.
Across 144 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$650
- Organogenesis Inc.$338
- VYNE Pharmaceuticals Inc.$199
- Sun Pharmaceutical Industries Inc.$141
- EPI Health, LLC$122
- Incyte Corporation$117
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,591100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 49 | $650 |
| Organogenesis Inc. | 16 | $338 |
| VYNE Pharmaceuticals Inc. | 10 | $199 |
| Sun Pharmaceutical Industries Inc. | 6 | $141 |
| EPI Health, LLC | 7 | $122 |
| Incyte Corporation | 6 | $117 |
| Kerecis Limited | 1 | $93 |
| Almirall LLC | 5 | $92 |
| Dermira, Inc. | 6 | $92 |
| Mayne Pharma Commercial LLC | 4 | $92 |
| Arcutis Biotherapeutics, Inc. | 5 | $91 |
| Pfizer | 5 | $90 |
| Dermavant Sciences, Inc. | 3 | $67 |
| LEO Pharma Inc. | 3 | $64 |
| Botanix SB Inc | 2 | $40 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $33 |
| Organon | 1 | $27 |
| Surgenex LLC | 1 | $26 |
| Medtronic | 1 | $24 |
| Biofrontera Inc. | 1 | $21 |
| AbbVie | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Mimedx Group, Inc. | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| Sandoz | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $18 |
| Amgen | 1 | $17 |
| Medline Industries LP | 1 | $16 |
| Merck | 1 | $13 |
| Aclaris Therapeutics, Inc. | 1 | $12 |
How this compares
$2,591 in reported general payments places this provider in the 55th percentile of 40 mohs-micrographic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 11 | $29,349 |
| Metronidazole | 193 | $9,973 |
| Betamethasone Dipropionate | 276 | $7,947 |
| Calcipotriene | 30 | $5,592 |
| Fluorouracil | 67 | $4,850 |
| Clobetasol Propionate | 113 | $4,692 |
| Azelaic Acid | 45 | $4,343 |
| Ciclopirox | 147 | $3,315 |
| Econazole Nitrate | 86 | $3,106 |
| Alclometasone Dipropionate | 171 | $3,050 |
| Clindamycin Phosphate | 126 | $2,576 |
| Triamcinolone Acetonide | 561 | $2,213 |
| Desonide | 86 | $2,064 |
| Tacrolimus | 35 | $2,052 |
| Ketoconazole | 175 | $1,946 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $19 | $29,34911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 40 mohs-micrographic surgery providers in Illinois.
Other mohs-micrographic surgery in Batavia
- Scott ZahnerHinsdale$55K
- Melanie ZahnerHinsdale$23K
- Kelly ParkNorthbrook$11K
- Owen KramerElmhurst$10K
- Todd JohnsonChicago$10K
- Simon YooChicago$10K
- Jeffrey McKennaCharleston$10K
- Daniel SchlessingerChicago$8K
- Aleksandar KrunicChicago$8K
- Ross PearlmanChicago$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.